[BSX] Boston Scientific Corp

Symbol: BSX Last Price: 12.70 Change: +0.20 (+1.57%) Website: click here

Headlines for [BSX]

• JNJ Today 08:32am
  Johnson & Johnson Inc The CYPHER Sirolimus-eluting Coronary Stent outperforms the Taxus Stent in people with diabetes according to Clinical Data in the Journal of the American College of Cardiology- In this multi-center more...
  
• BSX 8/20/2008 11:50am
  Boston Scientific Corp Will reportedly close an Ireland plant in 2009 that currently employes 240 employees(< 1% of workforce) - unconfirmed report
  
• BSX 8/14/2008 12:21pm
  Boston Scientific Corp FDA discloses Class I recall for NexStent system- The recall covers the NexStent Monorail, NexStent Carotid Stent and Monorail Delivery System, distributed from June 19, 2007, through May 5, 2008. - more...
  
• BSX 8/13/2008 08:33pm
  Boston Scientific Corp WSJ says a heart stent manufactured by BSX and expecting approval for US sales is backed by flawed research - BSX submitted the results of the 2006 trial to the FDA to gain US approval for the Taxus more...
  
• BSX 8/13/2008 11:43am
  Boston Scientific Corp Reportedly suing Medtronic over graft patents
  

Healthcare sector headlines

• BRL Today 12:19pm
  Barr Pharmaceuticals Inc Subsidiary receives approval for generic version of Razadyne tablets- Co. received final approval from the U.S. FDA to manufacture and market a generic version of Ortho McNeil Janssen's Razadyne, 4 more...
  
• THR.BE Today 12:07pm
  ThromboGenics Reports H108 Rev €30.3M; Appoints Dr. Patrik De Haes CEO- As of June 30, 2008, ThromboGenics had €40.4M in cash and cash equivalents. - Co. expects to see an increase in its operating expenses in more...
  
• HITK Today 11:54am
  Hi-Tech Pharmacal Update: Files suit to confirm market exclusivity status regarding Dorzolamide and Timolol Ophthalmic Solution- Note: dorzolamide and timolol ophthalmic solution is the generic for Merck's Cosopt
  
• ELN Today 11:41am
  Elan Corp PLC Morgan Stanley Initiates ELN with Overweight (timing uncertain)- price target €12
  
• WX Today 09:39am
  Wuxi Pharmatech Inc ADR UPDATE: Merrill Lynch Resumed WX with Buy, price target: $23- pre-open